ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,111Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 789

$1.63M Total Retail Price of All Prescriptions

Rank: 16 out of 789

971 Patients Receiving at Least One Drug in Part D
87% Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Indiana
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

6% of this provider’s 971 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

15% of this provider’s 971 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Indiana
FUROSEMIDE 1,116 1,022 177 1 7
AMLODIPINE BESYLATE 996 913 211 2 4
LEVOTHYROXINE SODIUM 908 765 161 3 1
POTASSIUM CHLORIDE 733 688 110 4 16
HYDROCODONE-ACETAMINOPHEN 691 555 146 S3 5 2
WARFARIN SODIUM 632 592 93 6 10
SIMVASTATIN 578 483 125 7 5
OMEPRAZOLE 577 535 116 8 6
LISINOPRIL 548 464 128 9 3
ATORVASTATIN CALCIUM 455 415 97 10 8
PRAVASTATIN SODIUM 455 405 98 10 13
GABAPENTIN 413 325 71 12 12
PANTOPRAZOLE SODIUM 398 346 92 13 26
PREDNISONE 385 316 136 14 40
CEPHALEXIN 383 344 207 15 73
CITALOPRAM HBR 368 334 77 16 24
METFORMIN HCL 359 293 67 17 9
METOPROLOL TARTRATE 353 331 70 18 11
LOSARTAN POTASSIUM 350 325 75 19 17
DONEPEZIL HCL 340 305 60 20 27
CLOPIDOGREL 330 268 60 21 19
HYDROCHLOROTHIAZIDE 326 300 60 22 14
ATENOLOL 302 282 64 23 21
CARVEDILOL 298 255 63 24 22
NAMENDA 290 263 25 25 25
TAMSULOSIN HCL 286 241 51 26 28
POLYETHYLENE GLYCOL 3350 268 210 51 27 56
SERTRALINE HCL 249 233 49 28 23
TRAMADOL HCL 244 227 58 29 20
RISPERIDONE 221 155 28 A 30 78
METOPROLOL SUCCINATE 215 176 48 31 15
LORAZEPAM 215 180 53 B 31 42
ESCITALOPRAM OXALATE 212 186 27 33 38
JANUVIA 196 191* 34 34 66
LEVOFLOXACIN 196 165 126 34 67
ALPRAZOLAM 196 164 38 B 34 18
ISOSORBIDE MONONITRATE ER 195 156 33 37 48
CYMBALTA 194 168 27 38 30
CIPROFLOXACIN HCL 189 154 108 39 64
LANTUS 188 150 27 40 49
FAMOTIDINE* 175 152 24 41 60
KLOR-CON M20 170 159 44 42 50
NEXIUM 168 145 28 43 34
TRAZODONE HCL 164 98 28 44 41
DIVALPROEX SODIUM 160 83 24 45 80
ZOLPIDEM TARTRATE 158 138 37 46 29
QUETIAPINE FUMARATE 153 135 15 A 47 68
ADVAIR DISKUS 149 101 32 48 55
RANITIDINE HCL 140 122 30 49 58
LOSARTAN-HYDROCHLOROTHIAZIDE 134 134 29 50 47
OXYBUTYNIN CHLORIDE 127 122* 33 51 101
AZITHROMYCIN 123 118* 72 52 54
CARBIDOPA-LEVODOPA 121 121 18 53 106
TRIAMTERENE-HCTZ 118 118 23 54 46
MIRTAZAPINE 113 95 21 55 52
MONTELUKAST SODIUM 112 92 21 56 51
HUMALOG 111 82 24 57 91
IPRATROPIUM-ALBUTEROL 111 106* 18 57 111
LANTUS SOLOSTAR 111 82 29 57 71
ALENDRONATE SODIUM 103 88 26 60 35
CELEBREX 103 98* 22 60 83
LISINOPRIL-HYDROCHLOROTHIAZIDE 103 98* 31 60 36
CRESTOR 102 97* 25 63 31
SYMBICORT 102 65 21 63 136
SPIRONOLACTONE 100 95* 24 65 59
SPIRIVA 99 78 15 66 61
GLIPIZIDE 98 93* 25 67 77
BUMETANIDE 96 91* 14 68 135
GLIPIZIDE ER 96 76 20 68 108
INVEGA 92 <11 <11 A 70 341
KLOR-CON 10 91 78 25 71 104
PROAIR HFA 88 38 38 72 44
CLONAZEPAM 86 41 11 B 73 57
CYCLOBENZAPRINE HCL 84 65 20 R 74 69
DILTIAZEM 24HR ER 84 79* 21 74 103
DIGOX 83 83 18 76 98
FENTANYL 82 77* 20 S2 77 75
ROPINIROLE HCL 81 81 16 78 72
CLONIDINE HCL 80 54 15 79 63
FLUOXETINE HCL 80 44 14 79 45
DIOVAN 80 75* 14 79 53
OXYCODONE-ACETAMINOPHEN 79 62 17 S2 82 85
DIVALPROEX SODIUM ER 78 <11 <11 83 174
VESICARE 76 <11 <11 84 148
SULFAMETHOXAZOLE-TRIMETHOPRIM 74 69* 46 85 95
LEVETIRACETAM 72 <11 <11 86 97
ALBUTEROL SULFATE 72 48 13 86 147
GLYBURIDE 70 65* 18 R 88 146
MECLIZINE HCL 69 64* 26 89 137
VALSARTAN-HYDROCHLOROTHIAZIDE 68 68 12 90 87
LEVEMIR FLEXPEN 67 <11 <11 91 132
BD ULTRA-FINE PEN NEEDLE 63 58* 26 92 94
TEMAZEPAM 63 63 15 B 92 133
HYDRALAZINE HCL 63 58* 12 92 74
AMITIZA 62 <11 <11 95 251
FINASTERIDE 62 62 15 95 114
FLUTICASONE PROPIONATE 62 57* 16 95 43
ALLOPURINOL 62 57* 18 95 32
CLOZAPINE 60 <11 <11 A 99 239
OXYBUTYNIN CHLORIDE ER 60 55* 12 99 110
GLIMEPIRIDE 59 54* 17 101 33
MELOXICAM 59 36 15 101 37
LYRICA 58 53* 11 103 84
NOVOLOG 57 44 15 104 92
BUSPIRONE HCL 57 52* 13 104 125
RANEXA 56 <11 <11 106 259
FENOFIBRATE* 56 <11 <11 106 79
ABILIFY 55 50* 11 A 108 134
DETROL LA 54 <11 <11 109 204
PHENYTOIN SODIUM EXTENDED 52 <11 <11 110 156
OLANZAPINE 52 <11 <11 A 110 100
ZETIA 51 46* 13 112 76
BENAZEPRIL HCL 51 39 12 112 90
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 12, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.